Study: Hospital-at-home patients have low mortality rates, few complications

Hospital-at-home patients have had a low mortality rate and few complications, a study by CMS researchers found.

Advertisement

Of the 11,159 acute-care patients treated at home under the CMS hospital-at-home waiver from Nov. 25, 2021, through March 20, 2023, only 0.34%, or 38, died unexpectedly, most related to COVID-19, according to the Nov. 3 study in JAMA Health Forum. Patients had “minimal complications” leading them to return to a brick-and-mortar hospital.

The study’s limitations include selection bias from participating hospitals and patients with conditions that could be cared for at home, the authors noted. CMS has extended the hospital-at-home waiver through Dec. 31, 2024.

Becker’s 3rd Annual Fall Chief Pharmacy Officer Summit is the top tier event that the people leading the future of pharmacy convene. This 3-day event is built specifically for Chief Pharmacy Officers and senior pharmacy leaders. The sessions examine the workforce, financial and clinical priorities shaping pharmacy today. Becker’s is where candid discussions flourish and new ideas thrive. Becker's 3rd Annual Fall Chief Pharmacy Officer Summit

Advertisement

Next Up in Digital Health

Advertisement

Comments are closed.